Unique anti-angiogenic effects, pharmacological targets and therapeutic mechanisms of Chinese herbal medicines for endometriosis

Liang B, Bo Liang, Rui Dong, Dong R, Sze Wan Hung, Li Y, Yiran Li, Yuezhen Lin, Wu L, Ling Wu, Zhang T, Tao Zhang, Gene Chi Wai Man, Hui Xu, Xu H, Jacqueline Pui Wah Chung, Chung JPW, Wang CC, Chi Chiu Wang
Genes & diseases · 2024 · vol. 11(5) , pp. 101166 · doi:10.1016/j.gendis.2023.101166 · PMID:38882012 · PMC11177055
other OA: gold CC-BY-4.0
📄 Open PDF Full text JSON View on PubMed View at publisher
⚙ AI-generated summary by gemini-2.5-flash-lite+body, 2026-08-08 ⓘ

This review elucidates the unique anti-angiogenic effects, pharmacological targets, and therapeutic mechanisms of Chinese herbal medicines used to treat endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

⚙ AI-generated deep summary by qwen3.7-flash, 2026-09-01 · read from full text ⓘ

The provided text contains only metadata, funding acknowledgments, and conflict of interest statements for a study titled "Unique anti-angiogenic effects, pharmacological targets and therapeutic mechanisms of Chinese herbal medicines for endometriosis." It does not include the abstract, methods, results, or conclusions necessary to summarize the actual research findings or population studied. Consequently, no specific scientific data or limitations can be extracted from this snippet alone. Relevance to endometriosis: The paper's title explicitly indicates it is centrally about endometriosis, focusing on the anti-angiogenic properties and therapeutic mechanisms of Chinese herbal medicines for this condition.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Full text 522 characters · extracted from epmc-fulltextxml · 4 sections · click to expand

Funding

This study was partially supported by the Strategic Seed Funding for Collaborative Research Scheme (SSFCRS) of the Chinese University of Hong Kong (CUHK, China) (No. 0670/22) and the National Natural Science Foundation of China (No. 82260948).

Conflict

The authors declare no conflict of interests.

Fn Group

Peer review under responsibility of Chongqing Medical University. Supplementary data to this article can be found online at https://doi.org/10.1016/j.gendis.2023.101166 .

Supplementary

The following are the Supplementary data to this article:

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

⚙ Ask this paper AI returns verbatim quotes from the full text · source: epmc-fulltextxml ⓘ

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. This is a recent paper (2024) — citers typically take a year or two to land, and the OpenAlex reference graph may still be filling in.

Source provenance

europepmc
last seen: 2026-09-14T06:17:53.580500+00:00
pubmed
last seen: 2026-09-14T06:15:18.527294+00:00
unpaywall
last seen: 2026-05-14T19:30:52.867331+00:00
License: CC-BY-4.0 · commercial use OK · attribution required
Courtesy of the U.S. National Library of Medicine